Fundraising FoxALTITUDE LIFE SCIENCE VENTURES — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Vir Biotechnology develops treatments for infectious diseases and oncology, leveraging immunology-focused scientific capabilities.
AI & Machine LearningBiotechDigital HealthMedical DevicesSan Francisco, US
Marianne De Backer(CEO)inHerbert Virgin(Executive Officer)Howard Horn(Executive Officer)inAlex Bangs(Executive Officer)inMarianne De Backer, M.Sc., Ph.D., MBA(President, Chief Executive Officer and Director)
BoardGeorge Scangos(Executive Officer, Director)
Co-investorsAlta PartnersARCH Venture PartnersGV (Google Ventures)SoftBank Vision Fund8VCDCVC (Data Collective)+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.